{"id":4380,"date":"2024-08-26T12:37:04","date_gmt":"2024-08-26T12:37:04","guid":{"rendered":"https:\/\/zobio.com\/?p=4380"},"modified":"2024-09-24T10:02:33","modified_gmt":"2024-09-24T10:02:33","slug":"innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i","status":"publish","type":"post","link":"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/","title":{"rendered":"Innovative NMR Strategy Provides Structure of First-in-Class Small Molecule Inhibitors of the Dual-Specificity Kinase MKK4 (MKK4i)"},"content":{"rendered":"<div id=\"pl-4380\"  class=\"panel-layout\" ><div id=\"pg-4380-0\"  class=\"panel-grid panel-has-style\" ><div class=\"panel-row-style panel-row-style-for-4380-0\" ><div id=\"pgc-4380-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-4380-0-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"0\" ><div class=\"with-icon panel-widget-style panel-widget-style-for-4380-0-0-0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t><h2 class=\"widget-title\">Innovative NMR Strategy Provides Structure of First-in-Class Small Molecule Inhibitors of the Dual-Specificity Kinase MKK4 (MKK4i)<\/h2>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><span data-contrast=\"auto\">As part of an international team, led by HepaRegeniX, ZoBio solved the structure of an inhibitor bound to the kinase MKK4 using a non-classical approach to structural elucidation with NMR. These efforts have recently been described in <a href=\"https:\/\/www.cell.com\/cell\/fulltext\/S0092-8674(24)00225-3\" target=\"_blank\" rel=\"noopener\">Cell<\/a> detailing the preclinical characterization and development of the clinical candidate HRX215, a first-in-class small molecule inhibitor of MKK4.<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<p><b><span data-contrast=\"auto\">M<\/span><\/b><span data-contrast=\"auto\">itogen-Activated Protein (MAP)\u202f<\/span><b><span data-contrast=\"auto\">K<\/span><\/b><span data-contrast=\"auto\">inase\u202f<\/span><b><span data-contrast=\"auto\">K<\/span><\/b><span data-contrast=\"auto\">inase\u202f<\/span><b><span data-contrast=\"auto\">4<\/span><\/b><span data-contrast=\"auto\">\u202f(MKK4) is a dual specific MAP2 kinase that was recently shown to be a master regulator of liver cell (hepatocyte) regeneration. Modulation of MKK4 activity therefore has profound therapeutic implication for patients suffering from chronic or acute liver disease. Including cirrhosis of the liver, primary liver tumors and cancer metastasized to the liver.\u00a0<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Initial efforts to obtain structural information for the inhibitor bound MKK4 kinase domain were focused on X-ray crystallography. While a structure was obtained, the resolution was insufficient to resolve the binding mode of the inhibitor. To support structure-based inhibitor design, the strategic shift was made to NMR. When conventional NMR methods yielded insufficient spectral quality, a close collaboration between the NMR spectroscopists and protein scientists at ZoBio enabled the use of a non-classical approach to NMR structural elucidation.<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">The method employed to finally resolve the inhibitor-bound MKK4 structure was based on selective labeling of methyl groups in the protein. To assign peaks and validate assignments, these sparse spectral data were supplemented with the structural data of a close homolog and multiple rounds of point-mutant design. Together, these experiments resulted in the unambiguous resolution of the structure of the MKK4-inhibitor complex.\u00a0<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">This study underscores the versatility of the techniques and expertise within ZoBio and demonstrates the strength of close collaboration among our scientists in solving challenging problems!<\/span><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>As part of an international team, led by HepaRegeniX, ZoBio solved the structure of an inhibitor bound to the kinase MKK4 using a non-classical approach to structural&#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"gpsa_enabled":false,"gpsa_required_form_ids":[],"gpsa_require_unique_form_submission":false,"gpsa_access_behavior":"show_message","gpsa_form_redirect_path":"","gpsa_requires_access_message":"","gpsa_access":[],"gpsa_content_loading_message":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-4380","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Innovative NMR Strategy Provides Structure of First-in-Class Small Molecule Inhibitors of the Dual-Specificity Kinase MKK4 (MKK4i) - ZoBio - Drug Discovery Technology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innovative NMR Strategy Provides Structure of First-in-Class Small Molecule Inhibitors of the Dual-Specificity Kinase MKK4 (MKK4i) - ZoBio - Drug Discovery Technology\" \/>\n<meta property=\"og:description\" content=\"As part of an international team, led by HepaRegeniX, ZoBio solved the structure of an inhibitor bound to the kinase MKK4 using a non-classical approach to structural...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/\" \/>\n<meta property=\"og:site_name\" content=\"ZoBio - Drug Discovery Technology\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-26T12:37:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-24T10:02:33+00:00\" \/>\n<meta name=\"author\" content=\"Content manager ~KB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Content manager ~KB\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/\"},\"author\":{\"name\":\"Content manager ~KB\",\"@id\":\"https:\/\/zobio.com\/online\/#\/schema\/person\/fcdd542fb16960e243f01d731e59d707\"},\"headline\":\"Innovative NMR Strategy Provides Structure of First-in-Class Small Molecule Inhibitors of the Dual-Specificity Kinase MKK4 (MKK4i)\",\"datePublished\":\"2024-08-26T12:37:04+00:00\",\"dateModified\":\"2024-09-24T10:02:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/\"},\"wordCount\":318,\"publisher\":{\"@id\":\"https:\/\/zobio.com\/online\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/\",\"url\":\"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/\",\"name\":\"Innovative NMR Strategy Provides Structure of First-in-Class Small Molecule Inhibitors of the Dual-Specificity Kinase MKK4 (MKK4i) - ZoBio - Drug Discovery Technology\",\"isPartOf\":{\"@id\":\"https:\/\/zobio.com\/online\/#website\"},\"datePublished\":\"2024-08-26T12:37:04+00:00\",\"dateModified\":\"2024-09-24T10:02:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/zobio.com\/online\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Innovative NMR Strategy Provides Structure of First-in-Class Small Molecule Inhibitors of the Dual-Specificity Kinase MKK4 (MKK4i)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/zobio.com\/online\/#website\",\"url\":\"https:\/\/zobio.com\/online\/\",\"name\":\"ZoBio - Drug Discovery Technology\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/zobio.com\/online\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/zobio.com\/online\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/zobio.com\/online\/#organization\",\"name\":\"ZoBio - Drug Discovery Technology\",\"url\":\"https:\/\/zobio.com\/online\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/zobio.com\/online\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/zobio.com\/online\/wp-content\/uploads\/2020\/01\/primary_logo_diap-ZoBio-RGBS.png\",\"contentUrl\":\"https:\/\/zobio.com\/online\/wp-content\/uploads\/2020\/01\/primary_logo_diap-ZoBio-RGBS.png\",\"width\":300,\"height\":371,\"caption\":\"ZoBio - Drug Discovery Technology\"},\"image\":{\"@id\":\"https:\/\/zobio.com\/online\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/zobio.com\/online\/#\/schema\/person\/fcdd542fb16960e243f01d731e59d707\",\"name\":\"Content manager ~KB\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/zobio.com\/online\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1e15929286368ee5275559d8b4bedc4a09a64b8968513d7c2286c3fd17fe93ee?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1e15929286368ee5275559d8b4bedc4a09a64b8968513d7c2286c3fd17fe93ee?s=96&d=mm&r=g\",\"caption\":\"Content manager ~KB\"},\"url\":\"https:\/\/zobio.com\/online\/author\/kasia\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Innovative NMR Strategy Provides Structure of First-in-Class Small Molecule Inhibitors of the Dual-Specificity Kinase MKK4 (MKK4i) - ZoBio - Drug Discovery Technology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/","og_locale":"en_GB","og_type":"article","og_title":"Innovative NMR Strategy Provides Structure of First-in-Class Small Molecule Inhibitors of the Dual-Specificity Kinase MKK4 (MKK4i) - ZoBio - Drug Discovery Technology","og_description":"As part of an international team, led by HepaRegeniX, ZoBio solved the structure of an inhibitor bound to the kinase MKK4 using a non-classical approach to structural...","og_url":"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/","og_site_name":"ZoBio - Drug Discovery Technology","article_published_time":"2024-08-26T12:37:04+00:00","article_modified_time":"2024-09-24T10:02:33+00:00","author":"Content manager ~KB","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Content manager ~KB","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/#article","isPartOf":{"@id":"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/"},"author":{"name":"Content manager ~KB","@id":"https:\/\/zobio.com\/online\/#\/schema\/person\/fcdd542fb16960e243f01d731e59d707"},"headline":"Innovative NMR Strategy Provides Structure of First-in-Class Small Molecule Inhibitors of the Dual-Specificity Kinase MKK4 (MKK4i)","datePublished":"2024-08-26T12:37:04+00:00","dateModified":"2024-09-24T10:02:33+00:00","mainEntityOfPage":{"@id":"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/"},"wordCount":318,"publisher":{"@id":"https:\/\/zobio.com\/online\/#organization"},"articleSection":["News"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/","url":"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/","name":"Innovative NMR Strategy Provides Structure of First-in-Class Small Molecule Inhibitors of the Dual-Specificity Kinase MKK4 (MKK4i) - ZoBio - Drug Discovery Technology","isPartOf":{"@id":"https:\/\/zobio.com\/online\/#website"},"datePublished":"2024-08-26T12:37:04+00:00","dateModified":"2024-09-24T10:02:33+00:00","breadcrumb":{"@id":"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/zobio.com\/online\/news\/innovative-nmr-strategy-provides-structure-of-first-in-class-small-molecule-inhibitors-of-the-dual-specificity-kinase-mkk4-mkk4i\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/zobio.com\/online\/"},{"@type":"ListItem","position":2,"name":"Innovative NMR Strategy Provides Structure of First-in-Class Small Molecule Inhibitors of the Dual-Specificity Kinase MKK4 (MKK4i)"}]},{"@type":"WebSite","@id":"https:\/\/zobio.com\/online\/#website","url":"https:\/\/zobio.com\/online\/","name":"ZoBio - Drug Discovery Technology","description":"","publisher":{"@id":"https:\/\/zobio.com\/online\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/zobio.com\/online\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/zobio.com\/online\/#organization","name":"ZoBio - Drug Discovery Technology","url":"https:\/\/zobio.com\/online\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/zobio.com\/online\/#\/schema\/logo\/image\/","url":"https:\/\/zobio.com\/online\/wp-content\/uploads\/2020\/01\/primary_logo_diap-ZoBio-RGBS.png","contentUrl":"https:\/\/zobio.com\/online\/wp-content\/uploads\/2020\/01\/primary_logo_diap-ZoBio-RGBS.png","width":300,"height":371,"caption":"ZoBio - Drug Discovery Technology"},"image":{"@id":"https:\/\/zobio.com\/online\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/zobio.com\/online\/#\/schema\/person\/fcdd542fb16960e243f01d731e59d707","name":"Content manager ~KB","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/zobio.com\/online\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1e15929286368ee5275559d8b4bedc4a09a64b8968513d7c2286c3fd17fe93ee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1e15929286368ee5275559d8b4bedc4a09a64b8968513d7c2286c3fd17fe93ee?s=96&d=mm&r=g","caption":"Content manager ~KB"},"url":"https:\/\/zobio.com\/online\/author\/kasia\/"}]}},"_links":{"self":[{"href":"https:\/\/zobio.com\/online\/wp-json\/wp\/v2\/posts\/4380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zobio.com\/online\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zobio.com\/online\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zobio.com\/online\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/zobio.com\/online\/wp-json\/wp\/v2\/comments?post=4380"}],"version-history":[{"count":8,"href":"https:\/\/zobio.com\/online\/wp-json\/wp\/v2\/posts\/4380\/revisions"}],"predecessor-version":[{"id":4432,"href":"https:\/\/zobio.com\/online\/wp-json\/wp\/v2\/posts\/4380\/revisions\/4432"}],"wp:attachment":[{"href":"https:\/\/zobio.com\/online\/wp-json\/wp\/v2\/media?parent=4380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zobio.com\/online\/wp-json\/wp\/v2\/categories?post=4380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zobio.com\/online\/wp-json\/wp\/v2\/tags?post=4380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}